Gilead CEO: 'We have ample supply' of remdesivir for hospitalized coronavirus patients
October 09, 2020 at 08:06 AM EDT
Gilead will have enough global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel O'Day told CNBC on Friday.
